文献速递临床试验与 GCP真实世界研究与卫生经济

Text4Heart II:改善心脏病患者用药依从性的随机对照试验方案

Text4Heart II - improving medication adherence in people with heart disease: a study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2018-01-25

主要结局为6个月时基于配药记录判定的用药依从比例,次要结局包括12个月用药依从性、健康行为复合评分、心血管危险因素、再入院及成本效果,并采用RE-AIM框架评估实施潜力。

要点

  • 针对急性冠脉综合征后患者,比较短信干预联合常规心脏康复与仅常规心脏康复。
  • 主要结局为6个月时基于配药记录的用药依从比例,随访至12个月。
  • 将开展成本效果分析,并用RE-AIM框架评估干预的采纳与可持续性。

核心结论

  • 该试验旨在确定Text4Heart II短信干预在急性冠脉综合征后患者中改善6个月和12个月用药及生活方式行为依从性的有效性,并评估其成本效果及实施潜力。

研究设计与样本

  • 参与者随机接受24周理论及证据驱动的个性化短信项目联合常规心脏康复,或仅常规心脏康复(对照)。
  • 结局在6个月和12个月评估,主要结局为6个月时基于配药记录的用药依从比例。

关键数值与推荐

  • 主要结局为6个月时基于配药记录判定的用药依从比例。
  • 次要结局包括12个月用药依从性、自报健康行为复合评分(身体活动、果蔬摄入、适度饮酒及吸烟状态)、自报用药依从性、心血管危险因素(血脂、血压)、再入院及相关住院事件(6个月和12个月)。
  • 将进行成本效果分析,并采用RE-AIM框架确定干预的采纳和可持续性。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cardiac rehabilitation (CR) is an essential component of contemporary management for patients with coronary heart disease, including following an acute coronary syndrome (ACS). CR typically involves education and support to assist people following an ACS to make lifestyle changes and prevent subsequent events. Despite its benefits, uptake and participation in tradition CR programs is low. The use of mobile technologies (mHealth) offers the potential to improve reach, access, and delivery of CR support. We aim to determine the effectiveness and cost-effectiveness of a text-messaging intervention (Text4Heart II) to improve adherence to medication and lifestyle change in addition to usual care in people following an ACS. A second aim is to use the RE-AIM framework to inform the potential implementation of Text4Heart II within health services in New Zealand. METHODS: Text4Heart II is a two-arm, parallel, superiority randomized controlled trial conducted in two large metropolitan hospitals in Auckland, New Zealand. Three hundred and thirty participants will be randomized to either a 24-week theory- and evidence-based personalized text message program to support self-management in addition to usual CR, or usual CR alone (control). Outcomes are assessed at 6 and 12 months. The primary outcome is the proportion of participants adhering to medication at 6 months as measured by dispensed records. Secondary outcomes include medication adherence at 12 months, the proportion of participants adhering to self-reported healthy behaviors (physical activity, fruit and vegetable consumption, moderating alcohol intake and smoking status) measured using a composite health behavior score, self-reported medication adherence, cardiovascular risk factors (lipids, blood pressure), readmissions and related hospital events at 6 and 12 months. A cost-effectiveness analysis will also be conducted. Using the RE-AIM framework, we will determine uptake and sustainability of the intervention. DISCUSSION: The Text4Heart II trial will determine the effectiveness of a text-messaging intervention to improve adherence to medication and lifestyle behaviors at both 6 and 12 months. Using the RE-AIM framework this trial will provide much needed data and insight into the potential implementation of Text4Heart II. This trial addresses many limitations/criticisms of previous mHealth trials; it builds on our Text4Heart pilot trial, it is adequately powered, has sufficient duration to elicit behavior change, and the follow-up assessments (6 and 12 months) are long enough to determine the sustained effect of the intervention. TRIAL REGISTRATION: Australian New Zealand Clinical Trials Registry, ID: ACTRN12616000422426 . Registered retrospectively on 1 April 2016.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Maddison R, Stewart R, Doughty R, et al. Text4Heart II - improving medication adherence in people with heart disease: a study protocol for a randomized controlled trial. Trials. 2018. PMID: 29370829. doi:10.1186/s13063-018-2468-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。